Biotechnology
Biopharmaceutical
Pharmaceutical
Intercept Pharmaceuticals
$68.649876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$68.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$3.03 (-4.23%) Today
$0.00 (0.00%) As of 5:05 PM EDT after-hours
Why Robinhood?
You can buy or sell ICPT and other stocks, options, ETFs, and crypto commission-free!
About ICPT
Intercept Pharmaceuticals, Inc. Common Stock, also called Intercept Pharmaceuticals, is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Read More Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.
Employees
483
Headquarters
New York, New York
Founded
2002
Market Cap
2.04B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
846.49K
High Today
$72.21
Low Today
$68.41
Open Price
$72.21
Volume
964.08K
52 Week High
$133.74
52 Week Low
$68.20
Collections
Biotechnology
Biopharmaceutical
Pharmaceutical
Health
Research And Development
Technology
ICPT News
Price Paid on Robinhood
26% Lower
Right Now
52 Week Low
$64.50
Average Price Paid
$92.77
52 Week High
$133.74
Analyst Ratings
86%
of 21 ratings
Buy
86%
Hold
10%
Sell
5%
ICPT Earnings
-$4.43
-$3.68
-$2.93
-$2.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 1, Pre-Market